eess.IVJun 11, 2025

A Cytology Dataset for Early Detection of Oral Squamous Cell Carcinoma

Authors: Garima Jain, Sanghamitra Pati, Mona Duggal, Amit Sethi, Abhijeet Patil, Gururaj Malekar, Nilesh Kowe, Jitender Kumar, 

Organizations: Indian Council of Medical Research-National Institute for Research in Digital Health & Data Science, New Delhi · Koita Centre of Digital Health, IIT Bombay · Indian Council of Medical Research, New Delhi · Department of Electrical Engineering, IIT Bombay · 

Abstract

Oral squamous cell carcinoma OSCC is a major global health burden, particularly in several regions across Asia, Africa, and South America, where it accounts for a significant proportion of cancer cases. Early detection dramatically improves outcomes, with stage I cancers achieving up to 90 percent survival. However, traditional diagnosis based on histopathology has limited accessibility in low-resource settings because it is invasive, resource-intensive, and reliant on expert pathologists. On the other hand, oral cytology of brush biopsy offers a minimally invasive and lower cost alternative, provided that the remaining challenges, inter observer variability and unavailability of expert pathologists can be addressed using artificial intelligence. Development and validation of robust AI solutions requires access to large, labeled, and multi-source datasets to train high capacity models that generalize across domain shifts. We introduce the first large and multicenter oral cytology dataset, comprising annotated slides stained with Papanicolaou(PAP) and May-Grunwald-Giemsa(MGG) protocols, collected from ten tertiary medical centers in India. The dataset is labeled and annotated by expert pathologists for cellular anomaly classification and detection, is designed to advance AI driven diagnostic methods. By filling the gap in publicly available oral cytology datasets, this resource aims to enhance automated detection, reduce diagnostic errors, and improve early OSCC diagnosis in resource-constrained settings, ultimately contributing to reduced mortality and better patient outcomes worldwide.

Explore similar work

Aug 21, 2026

Robust Lightweight Deep Learning Models for Oral Cancer Screening

Oral cancer is a leading cause of mortality in low-to-middle-income countries, where a shortage of specialists delays diagnosis. While point-of-care screening via smartphones offers a scalable solution, developing robust AI for resource-constrained settings poses significant challenges, including class imbalance in training data, variable data quality, and computational constraints on edge devices. In this paper, we present the optimisation of lightweight deep learning models for smartphone-based oral cancer screening. Using a diverse, multi-centre retrospective dataset of approximately 30,000 images acquired over a decade, we systematically evaluate state-of-the-art convolutional, transformer, and hybrid architectures. Through rigorous pipeline ablation, we demonstrate that directly optimising hybrid architectures for the edge strictly outperforms computationally heavy paradigms, such as large models or knowledge distillation. Furthermore, interpretability analysis and simulated noise-stress tests revealed that the system anchors on clinical features and remains robust to unstructured sensor noise, despite vulnerabilities to impulse bit errors. In the held-out test set, our optimised MobileViTv2 models achieved an average sensitivity of 83.2 ±\pm 1.5% and an average specificity of 86.0 ±\pm 0.8%, with the best model exhibiting 87.4% sensitivity, 86.5% specificity, and a critical negative predictive value of 97.2% with reference to specialist labels. These results confirm that with targeted architectural selection and streamlined optimisation, interpretable and robust lightweight AI models exhibit high potential for edge deployment to enable automated triage in primary care settings.
Nov 1, 2026

Deep Learning for Cervical Cytology Screening: Methods, Algorithms, Challenges and Prospects

Cervical cancer remains a leading cause of cancer death among women, with more than 90% of deaths occurring in low- and middle-income countries, where cytology screening is constrained by a shortage of trained cytopathologists. Deep learning has made automated cytology screening increasingly feasible, but the literature is fragmented across cell, patch and whole-slide-image scales, task formulations and supervision regimes, hindering comparison and clinical translation. This Review synthesizes the deep learning literature for cervical cytology screening, organizing the field along three axes---data scale, functional task and supervision---and distinguishing two clinical roadmaps: whole-slide-image confidence aggregation and cell-level detection with Bethesda classification. We examine 16 publicly available or publicly documented cytology datasets alongside the CAISHI histopathology dataset, compare quantitative performance while exposing incomparable metrics and data leakage, and assess commercial systems, regulatory status, HPV-era screening pathways and low-resource deployment. Single-cell accuracy on Herlev and SIPaKMeD has plateaued, but this reflects benchmark saturation rather than clinical readiness; prospective and randomized evidence is emerging but remains limited. We consolidate the evidence into five challenge areas---data and benchmarks, architecture and label-efficient learning, trustworthy AI, clinical translation and health economics, and evaluation and reproducibility---and provide an evidence-to-agenda map and a deployment decision matrix. Progress now depends on multi-center benchmarks, externally validated label-efficient methods, calibrated and fair predictions, and pragmatic clinical trials rather than further gains on saturated single-cell benchmarks.
Jun 12, 2026

Towards Global AI-Driven Cervical Cancer Screening

The global elimination of cervical cancer is a key public health goal set by the World Health Organization (WHO), with screening programs reducing mortality by up to 80%. However, access to experts and biopsy services is limited in low- to middle-income countries (LMICs). Deep learning (DL)-based algorithms offer promising support for screening, but most existing approaches have been developed and validated on private datasets from single countries. We present the first DL-based approach to cervical cancer screening validated on data from multiple countries. Technically, we phrase the problem of detecting and classifying lesions in colposcopy images as a multi-task learning problem, in which we simultaneously perform image-level classification and lesion segmentation. Our model was trained on a private data set of acid stain colposcopy images with manually generated lesion segmentation masks and corresponding histopathological results, employing extensive data augmentation to address image variability. In an in-distribution validation with pathology results serving as ground truth, our algorithm outperformed medical experts (Balanced Accuracy: 0.68 vs 0.64) in CIN1- (Cervical intraepithelial neoplasia grade 1 or lower) versus CIN2+ (grade 2 or higher) classification. External validation on four colposcopy data sets from four countries featuring radical differences in prevalence and patient characteristics yielded superior performance of our method compared to baseline methods. Performance variability across countries was high with AUC values ranging from 0.54 - 0.80. Overall, algorithm performance varied with age, transformation zone (cervical area most prone to lesion development), presence of comorbidities and pathognomonic signs, with comorbidities having by far the largest negative effect. Future work should focus on improving model robustness and generalizability.